ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AZN Astrazeneca Plc

11,988.00
-38.00 (-0.32%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -38.00 -0.32% 11,988.00 12,014.00 12,018.00 12,144.00 11,882.00 12,070.00 2,340,814 16:35:09
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 45.81B 5.96B 3.8415 31.28 186.27B
Astrazeneca Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AZN. The last closing price for Astrazeneca was 12,026p. Over the last year, Astrazeneca shares have traded in a share price range of 9,461.00p to 12,210.00p.

Astrazeneca currently has 1,550,189,338 shares in issue. The market capitalisation of Astrazeneca is £186.27 billion. Astrazeneca has a price to earnings ratio (PE ratio) of 31.28.

Astrazeneca Share Discussion Threads

Showing 6026 to 6045 of 6150 messages
Chat Pages: 246  245  244  243  242  241  240  239  238  237  236  235  Older
DateSubjectAuthorDiscuss
15/11/2023
17:07
A failure is a failure, simples!
dudishes
15/11/2023
16:26
Blackhorse23 filtered.
faz
15/11/2023
16:03
Could certainly do with some good news here. Hitting the 2023 lows now 😳
philanderer
15/11/2023
10:27
Money moving to APH , excellent healthcare dividend company
blackhorse23
15/11/2023
06:36
WRT reaction, smallpox jab had 1 in 100K reactions, in a group of Royal Navy men.

Mr Watkins, Welsh, was found to have a hole in his heart.

Mr Evershed was found to have bowel cancer.

In both cases, 19yrs of age.

Both of these issues are recorded at the Journal.

dudishes
14/11/2023
10:05
About time all the directors took their companies jabs and left to rot in jail
bob reno
10/11/2023
15:42
£100 chart support about to go..... £97 next stop.
philanderer
10/11/2023
09:56
2020 pre roll out ........... "It was pure evil they received permission to administer the unproven vaxxeen to children !!!"

10-15yrs is the normal trial period .....these jabs by passed the animal trials ffs !!

On Oct. 16, Pfizer’s CEO indicated the company would likely file for FDA Emergency Use Authorization for its experimental BNT162b2 vaccine in late November. That statement came three days after Pfizer announced that it had received FDA permission to administer the unproven vaccine to children as young as 12, becoming the first company in the U.S. to include young participants in Phase 3 trials. In the UK, Oxford and AstraZeneca gained approval to test their vaccine in children aged 5-12 back in May, a couple of months before two of their adult clinical trial participants developed transverse myelitis.

bob reno
10/11/2023
08:34
Money moving to APH
blackhorse23
09/11/2023
12:53
Settled for 3pts.

cheers

dudishes
09/11/2023
12:16
10480, another good bet imo?
dudishes
09/11/2023
12:06
We have licensed a weight loss drug! From a Chinese company though. It's in phase one trials , taken in pill form and based on research to date low on side effects and effective at low doses.
smcni1968
09/11/2023
11:35
https://www.londonstockexchange.com/news-article/APH/notification-of-major-holdings/16203593
blackhorse23
09/11/2023
11:16
Just two that I know of.
dudishes
09/11/2023
10:23
Nicey bouncey! 10449 for 142pts.

Difficult to make this up?

dudishes
09/11/2023
09:10
Stop chatting, get stuck in. 10307!

Dinner money?

dudishes
09/11/2023
08:24
News Highlights: Top Company News of the Day
09 November 2023 - 08:15AM
Dow Jones News



AstraZeneca Ups Core EPS Guidance Despite Profit Miss


AstraZeneca raised its full-year guidance for core earnings per share and total revenue excluding Covid-19 medicines despite a lower third-quarter profit that missed forecasts.

adrian j boris
09/11/2023
07:12
Updated guidance on non Covid revenue from high single digit growth to low teens growth is excellent news.Development pipeline of drugs also looks very promising.See where the market expectations were this morning, but I think we will get an significant uptick IMO.
our haven
09/11/2023
07:10
As with flu jab, you are warned.

If reaction occurs, it is up to relevant health services to take care of the patient.

Compensation, I expect, will be denied

dudishes
09/11/2023
00:27
Oxford AstraZeneca Covid jab was ‘defective’, claims landmark legal case
philanderer
Chat Pages: 246  245  244  243  242  241  240  239  238  237  236  235  Older

Your Recent History

Delayed Upgrade Clock